Should gastroenterologists prescribe cannabis? The highs, the lows and the unknowns

doi:10.12998/wjcc.v11.i18.4210

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 18

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4756)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-2) series.

Item

Count

PDF

154

WORD

HTML

3018

Figures (1-4)

463

Tables (1-2)

399

Sum=4058

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

159

Download

345

Sum=504

Jun 26, 2023 (publication date) through Apr 6, 2025

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Clin Cases. Jun 26, 2023; 11(18): 4210-4230
Published online Jun 26, 2023. doi: 10.12998/wjcc.v11.i18.4210

Full Size Figure Download Figure

Figure 3 Pathway of cannabis hyperemesis syndrome. CNS: Central nervous system; THC: Tetrahydrocannabinol; CBD: Cannabidiol; CB1: Cannabinoid receptor type 1; CB2: Cannabinoid receptor type 2.

Citation: Samuel S, Michael M, Tadros M. Should gastroenterologists prescribe cannabis? The highs, the lows and the unknowns. World J Clin Cases 2023; 11(18): 4210-4230
URL: https://www.wjgnet.com/2307-8960/full/v11/i18/4210.htm
DOI: https://dx.doi.org/10.12998/wjcc.v11.i18.4210